Publicaciones en las que colabora con ROBERTO ALFONSO ALONSO FERNÁNDEZ (17)

2023

  1. A mutation responsible for impaired detection by the Xpert SARS-CoV-2 assay independently emerged in different lineages during the SARS-CoV-2 pandemic

    BMC Microbiology, Vol. 23, Núm. 1

  2. Demographic, clinical and microbiological characteristics of the first 30 human monkeypox confirmed cases attended in a tertiary hospital in Madrid (Spain), during the May-June 2022 international outbreak

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 36, Núm. 2, pp. 194-200

  3. Long term SARS-CoV-2-specific cellular immunity after COVID-19 in liver transplant recipients

    Journal of Microbiology, Immunology and Infection, Vol. 56, Núm. 3, pp. 526-536

  4. Pneumocystis jirovecii Pneumonia Diagnostic Approach: Real-Life Experience in a Tertiary Centre

    Journal of Fungi, Vol. 9, Núm. 4

2022

  1. Decreased Long-Term Severe Acute Respiratory Syndrome Coronavirus 2–Specific Humoral Immunity in Liver Transplantation Recipients 12 Months After Coronavirus Disease 2019

    Liver Transplantation, Vol. 28, Núm. 6, pp. 1039-1050

  2. Different performance of three point-of-care SARS-CoV-2 antigen detection devices in symptomatic patients and close asymptomatic contacts: a real-life study

    Clinical Microbiology and Infection, Vol. 28, Núm. 6, pp. 865-870

  3. Incidence of Candidemia Is Higher in COVID-19 versus Non-COVID-19 Patients, but Not Driven by Intrahospital Transmission

    Journal of Fungi, Vol. 8, Núm. 3

  4. Nosocomial Transmission of SARS-CoV-2 Involving Vaccinated Health Care Workers

    Microbiology Spectrum, Vol. 10, Núm. 1

2021

  1. Heart and liver transplant recipients from donor with positive SARS-CoV-2 RT-PCR at time of transplantation

    Transplant Infectious Disease

  2. Inference of active viral replication in cases with sustained positive reverse transcription-PCR results for SARS-CoV-2

    Journal of Clinical Microbiology, Vol. 59, Núm. 2

  3. Invasive pulmonary aspergillosis in the COVID-19 era: An expected new entity

    Mycoses, Vol. 64, Núm. 2, pp. 132-143

  4. Utility of 1,3 β-d-glucan assay for guidance in antifungal stewardship programs for oncologic patients and solid organ transplant recipients

    Journal of Fungi, Vol. 7, Núm. 1, pp. 1-12

2020

  1. Clinical Relevance and Prognostic Value of Persistently Negative (1,3)-β-D-Glucan in Adults with Candidemia: A 5-year Experience in a Tertiary Hospital

    Clinical Infectious Diseases, Vol. 70, Núm. 9, pp. 1925-1932

2018

  1. Fungaemia caused by rare yeasts: Incidence, clinical characteristics and outcome over 10 years

    Journal of Antimicrobial Chemotherapy

2016

  1. The current treatment landscape: The need for antifungal stewardship programmes

    Journal of Antimicrobial Chemotherapy, Vol. 71, pp. ii5-ii12

2015

  1. Candida biomarkers in patients with candidaemia and bacteraemia

    Journal of Antimicrobial Chemotherapy, Vol. 70, Núm. 8, pp. 2354-2361

2014

  1. Potential role of Candida albicans germ tube antibody in the diagnosis of deep-seated candidemia

    Medical Mycology, Vol. 52, Núm. 3, pp. 270-275